Pluronic F127 diacrylate (F127DA) nano-micelle crosslinked methacrylated hyaluronic acid (MeHA) hydrogels (NMgels) with strong compressive properties have been demonstrated in our previous study. The current study further focuses on how the F127DA micelles and long-term swelling affect the mechanical performance of hydrogels from the view of in vitro/in vivo applications. Co-contributions of the F127DA micelles and MeHA to the compression performance are first investigated through mechanical analysis and cyclic loading/unloading tests before and after swelling. The optimized NMgel with F127DA micelles of 15 wt% and MeHA of 1.5 wt% (F15H1.5) exhibits a low swelling ratio and a well-maintained network in pH = 7.4 phosphate buffered saline. The abundant hydration significantly affects the initial mechanical properties of the hydrogels. After swelling, the compressive strength, modulus and fracture energy of F15H1.5 NMgel decrease from ∼3.44 MPa, ∼312 kPa and ∼407.5 kJ m−3 to 0.59 MPa, ∼55 kPa, and ∼81.8 kJ m−3, respectively. The energy dissipation of the first loading–unloading cycle dramatically decreases from ∼21.5 kJ m−3 to ∼6.0 kJ m−3 as well. Nevertheless, the gel still retains excellent stiffness, toughness and self-recovery due to the dense and strong micelle linkages. In vivo studies show that the implantation of F15H1.5 hydrogel in thyroid cartilage defects of rabbit larynx effectively promotes the regeneration of cartilage after 8 weeks. These results indicate that the stiff NMgel is a promising cartilage tissue engineering scaffold for the regeneration of cartilage in vivo.
Hydrogel microspheres are flexible microstructures with many fascinating functions, such as three-dimensional cell culture, injection therapy, drug delivery, organoids and microtissues construction. The traditional methods of manufacturing hydrogel microspheres more or less have some shortcomings, such as atomization/emulsion method with uneven sizes; piezoelectric-/thermal-/electric-assisted inkjet with high cell damage and unknown cell growth effects; microfluidic manufacturing with sophisticated microdevices etc, which lead to poor user experiences. Here, we designed a user-friendly microfluidic device to generate hydrogel microspheres with sharp needles that can be replaced at will. Specifically, a commercial tapered opening sharp needle was inserted into a transparent silicone tube with the tapered opening facing the upper wall of the silicone tube. Then, gelatin methacrylate (GelMA) solution and paraffin oil were pumped into the sharp needle and the silicone tube respectively. GelMA microdroplets were formed under the shear stress of the silicone tube and the oil phase, and after being photo-crosslinked in situ , GelMA microspheres with uniform and adjustable sizes can be generated. Due to the simplicity of our original device, heterogeneous microspheres such as Janus, core–shell and hollow microspheres can be easily manufactured by simple modification of the device. In addition, we demonstrated the strong flexibility and maneuverability of the microspheres through macroscopic free assembly. Finally, we prepared different cell-laden GelMA microspheres, and the cells showed stretching behavior similar to that in vivo after a short period culture, which indicated the high bioactivity of GelMA microspheres. Meanwhile, we cultured the Janus cell-laden GelMA microspheres and the assembly of cell-laden GelMA microspheres, where the cells stretched and interacted, demonstrating the potential of GelMA microspheres for co-culture and fabrication of large-scale tissue constructs. In view of the above results, our user-friendly microfluidic manufacturing method of hydrogel microspheres with sharp needles will provide great convenience to relevant researchers.
Drug-eluting stents (DES) have been widely applied for saving the life of patients with coronary artery diseases (CADs). However, conventional polymers such as polylactic acid (PLA) and poly (lactic-co-glycolic acid) (PLGA), which are widely applied for drug-eluting stents studies, have serious bulk erosion problems, like high local acidity and poor mechanical properties. Instead, we chose surface erosion polymer poly (1, 3-trimethylene carbonate) (PTMC) as a drug carrier in this study. Here, we fabricated and characterized a novel durable-polymer drug-eluting 316 L stainless steel (SS) stent, in which the inner surface was coated with a Ti–O film using the magnetron sputtering method to promote the growth of endothelial cells (ECs). On the outer layer of the stent, first, a Ti–O film was deposited and, then, on top of it a rapamycin-loaded PTMC coat was deposited using the ultrasonic atomization spray method. This dual coating inhibited the migration and expansion of smooth muscle cells (SMCs). The drug coating also inhibited the adhesion/activation of platelets. In tests on dogs, it was found the novel stent promoted re-endothelialization and reduced restenosis, in contrast to the plain SS stent. Thus, the novel stent may have promise for use in treating patients with CAD.
A pre-shear bioprinting strategy of oriented porous cell-laden hydrogel microfiber to construct anisotropic tissues is first proposed. Different cells encapsulated in the oriented microfibers exhibit oriented growth behaviors similar to that in vivo.